Hair loss is a potential side effect of weight loss medications, caused by a condition called telogen effluvium, which can be ...

Dietitian warns there are potential genetic influences that can change the way the body responds to weight-loss drugs ...

As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.

As of January, New Hampshire’s Medicaid program has ended coverage for GLP-1 drugs like Saxenda, Wegovy and Zepbound for ...

For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense.

A study in Nature found a specific genetic variant that may boost the effectiveness of GLP-1 weight-loss drugs like ...